Robotic Radiotherapy Market

The report "Robotic Radiotherapy Market by Product (System, Software, 3D Camera), Technology (LINAC, Stereotactic, Particle Therapy), Application (Lung, Breast, Colorectal), End-User (Hospitals, Radiotherapy Centres), & Region - Global Forecast to 2028", size is expected to grow from an estimated USD 1.1 billion in 2023 to USD 1.9 billion by 2028, at a CAGR of 11.9%. The growth of this market is majorly driven by factors such as the increasing demand for non-invasive treatments, a rise in cancer prevalence, and the widespread adoption of radiotherapy therapy. Additionally, escalating healthcare spending in developing nations, augmented government and private investments, as well as the increasing adoption of radiation therapy, contribute to the market's growth trajectory during the forecast period.

Browse 180 market data Tables and 45 Figures spread through 270 Pages and in-depth TOC on "Robotic Radiotherapy Market by Product (System, Software, 3D Camera), Technology (LINAC, Stereotactic, Particle Therapy), Application (Lung, Breast, Colorectal), End-User (Hospitals, Radiotherapy Centres), & Region - Global Forecast to 2028"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/robotic-radiotherapy-market-122256158.html

The 3D cameras (SGRT) segment is expected to register the highest growth in the forecast period of 2023-2028.

Based on the product, the radiotherapy systems are segmented into radiotherapy systems, software, 3D cameras (SGRT), and others. The radiotherapy systems segment commanded the largest share of the global robotic radiotherapy market in 2022, whereas the 3D cameras (SGRT) segment is projected to grow at the highest CAGR during the forecast period.

SGRT has gained widespread acceptance among cancer facilities worldwide due to its capacity to provide non-invasive, real-time, six-dimensional patient positioning and monitoring throughout radiation therapy treatment. This capability ensures precise treatment administration.

 SGRT presents a superior and swifter approach to treating brain tumors compared to invasive technologies or LINAC-based stereotactic radiosurgery. Its increasing adoption is attributed to its effectiveness in radiotherapy for breast cancer when combined with deep inspiration breath hold (DIBH) and voluntary-DIBH (VDIBH), which minimizes radiation-induced damage to the heart. Additionally, the expanding utilization of SGRT in whole-brain radiation therapy (WBRT) and the focus of industry players on introducing innovative 3D cameras and expanding their distribution networks are expected to bolster the growth of this segment in the foreseeable future.

The linear accelerators segment, by technology, is expected to register the market share of the global robotic radiotherapy market in 2023.

Based on technology, the global robotic radiotherapy market is segmented into linear accelerators, stereotactic radiation therapy systems, and particle therapy.

The linear accelerators segment is expected to account for the largest share of the indoor monitors market in 2023, primarily due to the significant advancements in recent years, enhancing their efficiency, precision, and versatility in delivering radiation therapy and ability to administer different types of radiation. Moreover, certain Linacs are equipped with onboard Cone Beam CT (CBCT) technology, facilitating real-time imaging prior to each treatment session. This guarantees accurate targeting, even in the presence of minor alterations in tumor position or patient anatomy. This represents another significant driver for the expansion of the market for fixed indoor monitors.

The lung cancer segment, by application, is expected to register the market share of the global robotic radiotherapy market in 2023.

Based on application, the global robotic radiotherapy market is segmented into prostate cancer, breast cancer, lung cancer, head & neck cancer, colorectal cancer, and other cancers. The lung cancer segment accounted for the largest share of the global robotic radiotherapy market in 2022. This segment is projected to reach USD 0.53 billion in 2028. The growth of the market primarily stems from the increasing occurrences of lung cancer, which may result in a greater caseload. Addressing this trend requires a focus on early detection, enhanced treatment alternatives, and concerted public health initiatives to alleviate the global burden of lung cancer. Additionally, contemporary lifestyles and dietary patterns are bolstering the expansion of this market segment.

Hospitals were the key end-users in the robotic radiotherapy market.

Based on end users, the robotic radiotherapy market is segmented into hospitals and independent radiotherapy centers.

Hospitals commanded the largest share of the global robotic radiotherapy market in 2022. The demand for radiotherapy systems among hospitals is driven by active government initiatives for effective testing, an increased number of research collaborations, and increased installation of robotic radiotherapy stations worldwide.

North America accounted for the largest share of the robotic radiotherapy market by region.

The global robotic radiotherapy market is segmented into four major regions, namely, North America, Europe, the Asia Pacific, and the Rest of the World. North America is the largest regional market for radiotherapy products, whereas the Asia Pacific market is estimated to grow at the highest CAGR during the forecast period. The largest share of North America can be attributed to the rapid adoption of radiotherapy systems, the The presence of a robust healthcare infrastructure, a rising number of cancer patients, substantial government investment to improve access to advanced cancer care through radiotherapy, and favorable reimbursement policies in the region contribute to the situation.

As of 2022, the robotic radiotherapy market was dominated by Siemens Healthineers AG (Germany)-Varian Medical Systems, Inc. (US), Elekta (Sweden), Accuray Incorporated (US), IBA Worldwide (Belgium), and ViewRay, Inc. (US), among others.

Don’t miss out on business opportunities in Robotic Radiotherapy Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]